What Do We Know about Individuals Who Are Assessed as Being at Moderate Risk for Future Fracture in Canada?

Joanna E M Sale, Ravi Jain, Kosalan Akilan, Kevin Senior, Dorcas Beaton, Earl Bogoch, Gilles Boire, Marie-Claude Beaulieu, David Lightfoot, Larry Funnell, Joanna E M Sale, Ravi Jain, Kosalan Akilan, Kevin Senior, Dorcas Beaton, Earl Bogoch, Gilles Boire, Marie-Claude Beaulieu, David Lightfoot, Larry Funnell

Abstract

Objective: We examined what was known about individuals in Canada who were assessed as being at moderate risk for future fracture.

Methods: A scoping review was conducted. Eligible articles were Canadian studies published from 2010 onwards reporting on primary data that included patients at moderate risk for future fracture. We limited the search to Canada as fracture risk categorization is unique to each country. Studies were identified by searching relevant databases. Two reviewers independently reviewed titles and abstracts to determine each study's eligibility. General information about each study, demographic information about the moderate risk groups (including tool used to determine moderate risk (Fracture Risk Assessment Tool (FRAX), Canadian Association of Radiologists and Osteoporosis Canada (CAROC)), and outcomes (number of patients: recommended treatment, prescribed treatment, initiating treatment, persisting with treatment after six months, who re-fractured, who died) were documented.

Results: We identified 1193 papers which were further screened for eligibility. Of the 1193 identified, 7 were eligible for the review but only 4 articles contained demographic or outcome data on moderate risk patients. In one study, 1.8% of moderate risk patients died over a mean 5.3 years of observation and in three studies, the risk of fracture was 5.9% over a median of 3 years of follow-up, 8.3% over a mean of 5.4 years, and 14.7% over 10 years of follow-up.

Conclusion: There is a wide knowledge gap in the literature concerning individuals who are assessed as moderate risk for future fracture in Canada.

Keywords: Management; Moderate Risk; Osteoporosis; Outcomes; Scoping Review.

Conflict of interest statement

Competing Interests of the Authors

None.

Figures

Figure 1
Figure 1
Results of literature search to identify studies on moderate risk patients.

References

    1. Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P National Osteoporosis Guideline Group. Diagnosis and Management of Osteoporosis in Postmenopausal Women and Older Men in the UK: National Osteoporosis Guideline Group (NOGG) Update 2013. Maturitas. 2013;75:392–396. .
    1. Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P, Wilkins M National Osteoporosis Guideline Group (NOGG) Guidelines for the Diagnosis and Management of Osteoporosis in Postmenopausal Women and Men from the Age of 50 Years in the UK. Maturitas. 2009;62:105–108. .
    1. Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD Scientific Advisory Council of Osteoporosis Canada. 2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada. Canadian Medical Association Journal. 2010;182:1864–1873. .
    1. Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA. Independent Clinical Validation of a Canadian FRAX Tool: Fracture Prediction and Model Calibration. Journal of Bone & Mineral Research. 2010;25:2350–2358. .
    1. Leslie WD, Berger C, Langsetmo L, Lix LM, Adachi JD, Hanley D, Ioannidis G, Josse R, Kovacs C, Towheed TE, Kaiser SM, Olszynski WP, Prior J, Jamal S, Kreiger N, Goltzman D Canadian Multicentre Osteoporosis Study Research Group. Construction and Validation of a Simplified Fracture Risk Assessment Tool for Canadian Women and Men: Results from the CaMos and Manitoba Cohorts. Osteoporosis International. 2011;22:1873–1883. .
    1. World Health Organization. Assessment of Fracture Risk and Application to Screening for Postmenopausal Osteoporosis. 1994.
    1. Arksey H, O’Malley L. Scoping Studies: Towards a Methodological Framework. International Journal of Social Research Methodology. 2005;8:19–32. .
    1. Levac D, Colquhoun H, O’Brien KK. Scoping Studies: Advancing the Methodology. Implementation Science. 2010;5:69. .
    1. Daudt HML, van Mossel C, Scott SJ. Enhancing the Scoping Study Methodology: A Large, Interprofessional Team’s Experience with Arksey and O’Malley’s Framework. BMC Medical Research Methodology. 2013;13:48. .
    1. Rumrill PD, Fitzgerald SM, Merchant WR. Using Scoping Literature Reviews as a Means of Understanding and Interpreting Existing Literature. Work. 2010;35:399–404.
    1. The Cochrane Collaboration. Cochrane Organizational Policy Manual. Oxford: 2014.
    1. Sale JEM, Beaton D, Posen J, Elliot-Gibson V, Bogoch E. Systematic Review on Interventions to Improve Osteoporosis Investigation and Treatment in Fragility Fracture Patients. Osteoporosis International. 2011;22:2067–2082. .
    1. Ganda KPM, Chen JS, Speerin R, Beasel J, Center JR, Eisman JA, March L, Seibel MJ. Models of Care for the Secondary Prevention of Osteoporotic Fractures: A Systematic Review and Meta-Analysis. Osteoporosis International. 2013;24:393–406. .
    1. Little EA, Eccles MP. A Systematic Review of the Effectiveness of Interventions to Improve Post-Fracture Investigation and Management of Patients at Risk of Osteoporosis. Implementation Science. 2010;5:80. .
    1. Bell K, Strand H, Inder WJ. Effect of a Dedicated Osteoporosis Health Professional on Screening and Treatment in Outpatients Presenting with Acute Low Trauma Non-Hip Fracture: A Systematic Review. Archives of Osteoporosis. 2013;9:167.
    1. Sale JEM, Beaton D, Posen J, Elliot-Gibson V, Bogoch E. Key Outcomes Are Usually Not Reported in Published Fracture Secondary Prevention Programs: Results of a Systematic Review. Archives of Orthopaedic and Trauma Surgery. 2014;134:283–289. .
    1. Sale JEM, Beaton D, Posen J, Bogoch E. Medication Initiation Rates Are Not Directly Comparable across Secondary Fracture Prevention Programs: Reporting Standards Based on a Systematic Review. Journal of Clinical Epidemiology. 2013;66:379–385. e4. .
    1. Brennan SL, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA. FRAX Provides Robust Fracture Prediction Regardless of Socioeconomic Status. Osteoporosis International. 2014;25:61–69. .
    1. Leslie WD, Lix LM, Wu X On behalf of the Manitoba Bone Density Program. Competing Mortality and Fracture Risk Assessment. Osteoporosis International. 2013;24:681–688. .
    1. Leslie WD, Kovacs CS, Olszynski WP, Towheed T, Kaiser SM, Prior JC, Josse RG, Jamal SA, Kreiger N, Goltzman D the CaMos Research Group. Spine-Hip T-Score Difference Predicts Major Osteoporotic Fracture Risk Independent of FRAX®: A Population-Based Report from CAMOS. Journal of Clinical Densitometry. 2011;14:286–293. .
    1. Leslie WD, Morin S, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA for the Manitoba Bone Density Program. Fracture Risk Assessment without Bone Density Measurement in Routine Clinical Practice. Osteoporosis International. 2012;23:75–85. .
    1. Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA. FRAX Underestimates Fracture Risk in Patients with Diabetes. Journal of Bone and Mineral Research. 2012;27:301–308. .
    1. Roux S, Cabana F, Carrier N, Beaulieu M, April PM, Beaulieu MC, Boire G. The World Health Organization Fracture Risk Assessment Tool (FRAX) Underestimates Incident and Recurrent Fractures in Consecutive Patients with Fragility Fractures. Journal of Clinical Endocrinology & Metabolism. 2014;99:2400–2408. .
    1. Allin S, Munce SSAM, Hawker G, Murphy K, Jaglal SB. Quality of Fracture Risk Assessment in Post-Fracture Care in Ontario, Canada. Osteoporosis International. 2013;24:899–905. .
    1. Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown J, Feldman S, Hanley DA, Hodsman A, Jamal SA, Josse RG, Kaiser SM, Kvern B, Siminoski K, Leslie WD for the Scientific Advisory Council of Osteoporosis Canada. Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada. Background and Technical Report. 2010:1–89.
    1. Bogoch ER, Cheung AM, Elliot-Gibson VIM, Gross DK. Preventing the Second Hip Fracture: Addressing Osteoporosis in Hip Fracture Patients. In: Waddell JP, editor. Fractures of the Proximal Femur. Elsevier; Maryland Heights: 2010.
    1. Wall M, Lohfeld L, Giangregorio L, Ioannidis G, Kennedy CC, Moser A, Papaioannou A, Morin SN. Fracture Risk Assessment in Long-Term Care: A Survey of Long-Term Care Physicians. BMC Geriatrics. 2013;13:109–115. .

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj